Current Value
$8.051 Year Return
Current Value
$8.051 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LMND | 34.46% | $2.36B | +106.25% | 0.00% |
MGEE | 33.76% | $3.40B | +34.78% | 1.85% |
IGMS | 33.65% | $108.82M | -82.34% | 0.00% |
SNDX | 33.64% | $1.11B | -39.00% | 0.00% |
PRAX | 32.72% | $1.31B | +80.54% | 0.00% |
QTRX | 31.39% | $339.78M | -60.13% | 0.00% |
ETR | 30.93% | $34.87B | +64.50% | 5.66% |
TTMI | 30.86% | $2.64B | +80.92% | 0.00% |
ROOT | 30.81% | $1.33B | +867.47% | 0.00% |
NGNE | 30.63% | $369.87M | -41.60% | 0.00% |
NTLA | 30.59% | $959.42M | -62.68% | 0.00% |
ATEC | 30.44% | $1.60B | -26.11% | 0.00% |
JHG | 30.43% | $6.69B | +46.71% | 3.68% |
NEO | 30.30% | $1.79B | -9.98% | 0.00% |
ALLO | 30.26% | $385.80M | -42.50% | 0.00% |
SXC | 29.48% | $861.95M | 0.00% | 4.26% |
CSV | 29.19% | $606.34M | +71.68% | 1.13% |
JEF | 28.99% | $15.30B | +89.56% | 1.73% |
VNT | 28.35% | $5.59B | +6.93% | 0.27% |
NXT | 28.18% | $6.50B | +5.45% | 0.00% |
SeekingAlpha
Discover three oversold biotech/biopharma stocks to watch amidst market volatility and the JP Morgan Healthcare event in San Francisco. Read up on our picks on Seeking Alpha.
SeekingAlpha
Avadel Pharmaceuticals' Lumryz sales guidance falls short, but the stock remains undervalued. Learn why AVDL stock presents an opportunity despite challenges.
Yahoo
Avadel Pharmaceuticals PLC (AVDL) reports significant revenue increase and outlines optimistic projections for 2025 amidst market expansion challenges.
Yahoo
-- Approximately $50.0 million of net revenue from sales of LUMRYZ™ estimated for the fourth quarter, a greater than 150% increase over $19.5 million for the comparable period in 2023 -- --2,500 patients on LUMRYZ as of December 31, 2024, including 600 patients that initiated therapy in the fourth quarter -- -- LUMRYZ net product revenue of $240 – $260 million in 2025, representing 50% year-over-year growth at the midpoint -- -- Management to host a conference call today at 4:30 p.m. ET -- DUBLI
Finnhub
DUBLIN - Avadel Pharmaceuticals plc , a company focused on transforming medicines to transform lives, announced that the Compensation Committee of Avadel's Board of Directors approved the grant of...
Yahoo
DUBLIN, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to twelve (12) new employees to purchase an aggregate of 131,700 ordinary shares under Avadel’s 2021 Inducement Plan. The awards were granted as an inducement material to the employee’s acceptance of employment with Avadel in ac
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ABEV | 0.02% | $28.47B | -32.96% | 6.04% |
IBN | 0.03% | $101.66B | +22.87% | 0.84% |
PAGP | -0.03% | $4.24B | +31.04% | 0.00% |
TLPH | 0.04% | $10.56M | -36.02% | 0.00% |
CPSH | 0.08% | $25.57M | -23.14% | 0.00% |
ZCMD | 0.10% | $35.55M | -56.76% | 0.00% |
VHC | 0.11% | $33.86M | +45.28% | 0.00% |
UFI | -0.11% | $112.71M | -1.28% | 0.00% |
CVS | 0.13% | $65.39B | -29.67% | 5.10% |
BRY | 0.14% | $383.93M | -21.65% | 8.82% |
ENIC | 0.15% | $4.07B | +5.00% | 0.00% |
TENB | -0.16% | $5.12B | -9.54% | 0.00% |
INOD | -0.16% | $1.08B | +351.77% | 0.00% |
SKX | 0.19% | $10.47B | +8.23% | 0.00% |
SE | -0.20% | $59.03B | +211.47% | 0.00% |
IDXX | 0.20% | $35.10B | -18.40% | 0.00% |
LTM | 0.21% | $8.28B | -100.00% | <0.01% |
SCKT | 0.21% | $11.48M | +37.40% | 0.00% |
WM | 0.22% | $84.69B | +14.99% | 1.42% |
DAN | 0.22% | $1.86B | -1.23% | 3.05% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BTCT | -30.86% | $23.92M | +5.78% | 0.00% |
ASC | -21.19% | $524.28M | -19.11% | 8.73% |
PSQH | -20.11% | $195.63M | -11.07% | 0.00% |
FLNG | -19.49% | $1.39B | -13.12% | 12.02% |
TNK | -16.92% | $1.53B | -19.77% | 2.33% |
INSW | -16.85% | $1.94B | -16.32% | 1.25% |
HII | -16.10% | $7.87B | -22.74% | 2.60% |
TEN | -16.03% | $562.38M | -22.30% | 8.01% |
PBT | -15.85% | $544.86M | -22.53% | 4.70% |
TRMD | -14.75% | $2.04B | -39.54% | 29.33% |
CMBT | -14.70% | $2.17B | -36.36% | 9.68% |
STNG | -14.69% | $2.89B | -17.07% | 3.06% |
RYAN | -14.12% | $8.38B | +53.28% | 0.66% |
MNOV | -14.02% | $91.72M | +23.03% | 0.00% |
DHT | -13.96% | $1.76B | -1.00% | 9.39% |
STG | -13.77% | $29.30M | -34.12% | 0.00% |
FRO | -13.64% | $3.89B | -20.86% | 11.38% |
NVGS | -13.47% | $1.16B | +3.93% | 1.21% |
ANIK | -13.10% | $237.11M | -27.88% | 0.00% |
WBA | -12.57% | $11.17B | -41.63% | 7.72% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BILZ | -0.02% | $616.99M | 0.14% |
CNBS | 0.17% | $11.68M | 0.77% |
DBMF | 0.31% | $1.39B | 0.85% |
DBB | 0.41% | $109.38M | 0.77% |
ULST | 0.46% | $549.72M | 0.2% |
DRLL | 0.62% | $323.08M | 0.41% |
IBMN | 0.66% | $484.25M | 0.18% |
CORN | 0.73% | $65.53M | 0.2% |
JUCY | 0.80% | $299.79M | 0.6% |
YOLO | -0.86% | $29.81M | 1.03% |
FCG | 1.18% | $449.90M | 0.6% |
KMLM | 1.25% | $330.04M | 0.9% |
THTA | 1.48% | $36.94M | 0.49% |
VRIG | 1.56% | $1.20B | 0.3% |
DUSB | -1.86% | $939.32M | 0.15% |
SOYB | -1.93% | $25.86M | 0.22% |
FLRT | 2.03% | $455.07M | 0.6% |
PGHY | 2.04% | $140.12M | 0.35% |
TAIL | -2.05% | $65.23M | 0.59% |
KRBN | 2.10% | $198.93M | 0.85% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
USDU | -14.58% | $396.64M | 0.5% |
CTA | -14.04% | $553.08M | 0.76% |
CANE | -10.50% | $11.58M | 0.29% |
UUP | -10.28% | $636.64M | 0.77% |
FTGC | -9.12% | $2.32B | 1.02% |
UNG | -8.35% | $852.04M | 1.06% |
VIXY | -8.25% | $195.31M | 0.85% |
USCI | -8.12% | $201.05M | 1.07% |
BCI | -7.72% | $1.37B | 0.26% |
EQLS | -7.38% | $9.15M | 1% |
TPMN | -6.49% | $41.98M | 0.65% |
QQA | -6.28% | $145.01M | 0% |
GSG | -6.08% | $1.06B | 0.75% |
MSOS | -5.87% | $445.91M | 0.83% |
DBA | -5.71% | $817.28M | 0.93% |
CMDY | -5.61% | $292.03M | 0.28% |
COMT | -5.14% | $714.17M | 0.48% |
FMF | -5.06% | $152.35M | 0.95% |
BCD | -4.84% | $242.75M | 0.3% |
SGOV | -4.57% | $31.44B | 0.09% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 28.59% | $5.97B | 0.35% |
IWO | 26.86% | $12.82B | 0.24% |
PTH | 26.80% | $116.47M | 0.6% |
IWC | 26.49% | $962.03M | 0.6% |
IWM | 25.62% | $72.20B | 0.19% |
VTWO | 25.61% | $12.56B | 0.1% |
PBE | 25.43% | $249.05M | 0.58% |
GSSC | 25.28% | $537.26M | 0.2% |
PSC | 24.93% | $757.78M | 0.38% |
IBB | 24.91% | $6.29B | 0.45% |
NULV | 24.91% | $1.64B | 0.26% |
SMMV | 24.60% | $305.01M | 0.2% |
ISCG | 24.48% | $650.49M | 0.06% |
ZIG | 24.33% | $47.45M | 0.84% |
IFRA | 24.21% | $3.20B | 0.3% |
XMLV | 24.14% | $787.77M | 0.25% |
XHE | 24.13% | $214.32M | 0.35% |
XPH | 24.01% | $159.10M | 0.35% |
RDIV | 23.95% | $798.28M | 0.39% |
XSHD | 23.94% | $64.09M | 0.3% |